Golimumab administered subcutaneously every 4 weeks in ankylosing spondylitis: 104-week results of the GO-RAISE study

Author(s):
Braun, J.; Deodhar, A.; Inman, R.D.; Heijde, D. van der; Mack, M.; Xu, S.P.; Hsu, B.
Published
2012
Publication type
Article / Letter to editor
Date issued
2012-05-31
Language
English
Is part of
Annals of the Rheumatic Diseases (2012), Vol. 71, no. 5, p. 661-667
hdl
1887/106091
doi
10.1136/ard.2011.154799